Current practice in Europe: How do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3109573 20 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Current practice in Europe: How do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
The purpose of the EP wire is to examine the clinical practice in the management of sustained ventricular tachycardia (VT), with special focus on diagnostic and therapeutic strategies. Forty-five European centres, all members of the EHRA-EP Research network completed the questions of the survey. There was an equal distribution of centres with high, medium, and low volume of activity. The most common aetiologies were: post-myocardial infarction ischaemic heart disease (55%), followed by idiopathic dilated cardiomyopathy (18%), and idiopathic VT (11%) and others (12%). Cardiac magnetic resonance imaging was performed in more than 50% of patients in 24 centres (62.2%). Invasive electrophysiological study was performed in more than 70% of patients in 16 centres (35.6%), between 51 and 70% in 9 (20%), below 50% in 20 (44.5%). In 39 centres (86.7%), implantable cardioverter defibrillator implantation was considered in all patients with structural heart disease and left ventricular ejection fraction <35%. In the setting of secondary prevention, early radiofrequency ablation of the VT was performed in more than 50% of the patients in only five centres (11.4%). Sequential endo-epicardial approach was reported in 52.2% of centres. © 2012 The Author.
Έτος δημοσίευσης:
2013
Συγγραφείς:
Proclemer, A.
Dagres, N.
Marinskis, G.
Pison, L.
Lip, G.Y.H.
Blomstrom-Lundqvist, C.
Περιοδικό:
Europace
Εκδότης:
Oxford University Press
Τόμος:
15
Αριθμός / τεύχος:
2
Σελίδες:
167-169
Λέξεις-κλειδιά:
antiarrhythmic agent; antiarrhythmic agent, cardiovascular magnetic resonance; clinical practice; congestive cardiomyopathy; Europe; heart left ventricle ejection fraction; heart ventricle tachycardia; human; hypertrophic cardiomyopathy; implantation; ischemic heart disease; medical society; nonischemic cardiomyopathy; priority journal; Review; article; cardiac imaging; catheter ablation; congestive cardiomyopathy; female; health care survey; heart infarction; heart muscle ischemia; heart stroke volume; heart ventricle tachycardia; implantable cardioverter defibrillator; male; multicenter study; nuclear magnetic resonance imaging, Anti-Arrhythmia Agents; Cardiac Imaging Techniques; Cardiomyopathy, Dilated; Catheter Ablation; Defibrillators, Implantable; Europe; Female; Health Care Surveys; Humans; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardial Ischemia; Stroke Volume; Tachycardia, Ventricular
Επίσημο URL (Εκδότης):
DOI:
10.1093/europace/eus436
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.